MARKET

TNYA

TNYA

Tenaya Therapeutics, Inc.
NASDAQ
0.6983
+0.0281
+4.19%
Opening 12:42 03/14 EDT
OPEN
0.6750
PREV CLOSE
0.6702
HIGH
0.7389
LOW
0.6554
VOLUME
3.54M
TURNOVER
--
52 WEEK HIGH
6.47
52 WEEK LOW
0.3941
MARKET CAP
113.53M
P/E (TTM)
-0.5330
1D
5D
1M
3M
1Y
5Y
1D
Tenaya Therapeutics Price Target Cut to $6.00/Share From $18.00 by Canaccord Genuity
Dow Jones · 1d ago
Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity
Dow Jones · 1d ago
Canaccord Genuity Maintains Buy on Tenaya Therapeutics, Lowers Price Target to $6
Benzinga · 1d ago
Tenaya Therapeutics Is Maintained at Overweight by Morgan Stanley
Dow Jones · 2d ago
Tenaya Therapeutics Price Target Cut to $5.00/Share From $15.00 by Morgan Stanley
Dow Jones · 2d ago
Morgan Stanley Maintains Overweight on Tenaya Therapeutics, Lowers Price Target to $5
Benzinga · 2d ago
Tenaya Therapeutics Price Target Cut to $9.00/Share From $18.00 by Chardan Capital
Dow Jones · 2d ago
Tenaya Therapeutics Is Maintained at Buy by Chardan Capital
Dow Jones · 2d ago
More
About TNYA
More
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. TN-401 is the Company’s adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC) due to disease-causing variants in the PKP2 gene. TN-301 is a small molecule for heart failure with preserved ejection fraction.
Recently
Symbol
Price
%Change

Webull offers Tenaya Therapeutics Inc stock information, including NASDAQ: TNYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNYA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNYA stock methods without spending real money on the virtual paper trading platform.